hereby clarifies the performance as follows: During 2019, the Company had the net profit of THB 3,229.3, which increased by 11.1% compared to the same period of 2018. Which the normalized net profit
corresponding period last year and the weighted average number of vans was at 336 vans up from 265 vans in the corresponding period last year, coupled with the wider range of 3rd party products for distribution
combined net profit of the commercial banking system was Baht 187.3 billion, a 5.7 percent decrease from last year, due to larger loan impairment charges set aside for credit losses in compliance with IFRS9
million. 25.10% of the equity value in SGAH that the Company will invest has a price range between USD 50.00 million and USD 100.00 million, or equivalent to between approximately Baht 1,761.00 and Baht
to approximately Baht 1,761.00 million. 25.10% of the equity value in SGAH that the Company will invest has a price range between USD 50.00 million and USD 100.00 million, or equivalent to between
of Solvay Biochemicals (Taixing) Limited (“SBT”) amounting to 218 MB. Summary of Performance For Q2 2017, the Company and its subsidiaries recorded net profit of 384 MTHB, increased by 249 MTHB or 5.0
herewith explanation and analysis of the Management as follows. 1. Income, gross profit, net profit Unit : Million Baht 1. Income 2017 2016 2015 Increase (decrease) 2017-2016 1.1 Construction material 207.44
. * Note Please find further information in the consolidated financial statements. 2 Summary of Performance For Q3 2017, the Company and its subsidiaries recorded net profit of 355 MTHB, increased by 267
ended 31 December 2018, for your information and publication. In the year 2018, the Company and its subsidiaries recorded net profit of 10,475 million baht while the same period last year the Company and
submit herewith explanation and analysis of the Management as follows. 1. Income, gross profit, net profit Unit : Million Baht 1. Income 2019 2018 2017 Increase (decrease) 2019-2018 1.1 Construction